Up a level |
Meier, Niklaus; Fuchs, Hendrik; Galactionova, Katya; Hermans, Cedric; Pletscher, Mark; Schwenkglenks, Matthias (2024). Cost-Effectiveness Analysis of Etranacogene Dezaparvovec Versus Extended Half-Life Prophylaxis for Moderate-to-Severe Haemophilia B in Germany PharmacoEconomics Open, 8(3), pp. 373-387. Springer 10.1007/s41669-024-00480-z